Concepedia

Publication | Open Access

Effect of SMURF2 Targeting on Susceptibility to MEK Inhibitors in Melanoma

DOIFull Paper Access

99

Citations

41

References

2012

Year

Michael P. Smith, Jennifer Ferguson, Imanol Arozarena, Robert Hayward, Richard Marais, Anna Chapman, Adam Hurlstone, Claudia Wellbrock
JNCI Journal of the National Cancer Institute

Abstract

Targeting SMURF2 may be a novel therapeutic approach for increasing the antitumor efficacy of MEK inhibitors.

References

YearCitations

Page 1